Suppr超能文献

印度 NDM-1 金属β-内酰胺酶的流行率和传播率不断上升:来自 SMART 研究(2009 年)的数据。

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).

机构信息

International Health Management Associates, Inc., Schaumburg, IL 60173, USA.

出版信息

J Antimicrob Chemother. 2011 Sep;66(9):1992-7. doi: 10.1093/jac/dkr240. Epub 2011 Jun 14.

Abstract

OBJECTIVES

To investigate the β-lactamase background of ertapenem non-susceptible isolates for the presence of the most commonly detected carbapenemase genes, bla(KPC), bla(OXA-48) and bla(VIM), and the newly described bla(NDM-1).

METHODS

Two hundred and thirty-five ertapenem-non-susceptible (MIC ≥ 0.5 mg/L) isolates of Enterobacteriaceae from the worldwide Study for Monitoring Antimicrobial Resistance Trends (SMART) 2009 programme were screened using a multiplex PCR for the presence of bla(KPC), bla(OXA-48), bla(VIM) and bla(NDM-1) genes. Extended-spectrum β-lactamase (ESBL) and AmpC genes (bla(ESBL) and bla(AmpC)) were identified using the Check-MDR CT101 microarray. DNA sequencing was performed to identify the bla(ESBL), bla(KPC) and bla(NDM-1) genes. Molecular typing was also performed to genetically characterize these isolates.

RESULTS

Sixty-six isolates (28%) had a carbapenemase gene, with bla(NDM-1) identified in 33 isolates including 2 isolates carrying both bla(NDM-1) and bla(OXA-48); other carbapenemase genes found included bla(KPC) (n = 23), bla(VIM) (n = 7) and bla(OXA-48) (n = 3). All bla(NDM-1)-carrying isolates were from patients in India and comprised five different species. With the exception of one isolate carrying only bla(NDM-1), all bla(NDM-1) carbapenemase-possessing isolates carried additional β-lactamases in various combinations: bla(ESBL) and bla(AmpC) (n = 18); bla(ESBL) (n = 10); bla(ESBL), bla(AmpC) and bla(OXA-48) (n = 2); and bla(AmpC) (n = 2). Except for bla(OXA-48)-carrying isolates, novel multilocus sequence types or enterobacterial repetitive intergenic consensus PCR patterns were observed along with clonal dissemination within and among sites.

CONCLUSIONS

A range of carbapenemase genes, associated with diverse ESBLs and/or AmpC backgrounds, were found among Enterobacteriaceae isolated during the study. Many of these ertapenem non-susceptible strains were clonally related and carried various combinations of β-lactamases.

摘要

目的

调查厄他培南不敏感分离株的β-内酰胺酶背景,以检测最常见的碳青霉烯酶基因,如 bla(KPC)、bla(OXA-48)和 bla(VIM),以及新发现的 bla(NDM-1)。

方法

采用多重 PCR 方法对来自全球监测抗菌药物耐药性趋势(SMART)2009 项目的 235 株厄他培南不敏感(MIC≥0.5mg/L)肠杆菌科分离株进行 bla(KPC)、bla(OXA-48)、bla(VIM)和 bla(NDM-1)基因检测。采用 Check-MDR CT101 微阵列检测超广谱β-内酰胺酶(ESBL)和 AmpC 基因(bla(ESBL)和 bla(AmpC))。对 bla(ESBL)、bla(KPC)和 bla(NDM-1)基因进行 DNA 测序鉴定。采用分子分型方法对这些分离株进行遗传特征分析。

结果

66 株(28%)携带碳青霉烯酶基因,其中 33 株携带 bla(NDM-1),包括 2 株同时携带 bla(NDM-1)和 bla(OXA-48);其他碳青霉烯酶基因包括 bla(KPC)(n=23)、bla(VIM)(n=7)和 bla(OXA-48)(n=3)。所有携带 bla(NDM-1)的分离株均来自印度患者,包括 5 个不同的种属。除 1 株仅携带 bla(NDM-1)外,所有携带 bla(NDM-1)碳青霉烯酶的分离株均携带不同组合的其他β-内酰胺酶:bla(ESBL)和 bla(AmpC)(n=18);bla(ESBL)(n=10);bla(ESBL)、bla(AmpC)和 bla(OXA-48)(n=2);以及 bla(AmpC)(n=2)。除携带 bla(OXA-48)的分离株外,还观察到新的多位点序列类型或肠杆菌重复基因间保守序列 PCR 模式,且在不同地点之间存在克隆传播。

结论

在本研究期间,肠杆菌科分离株中存在多种碳青霉烯酶基因,与不同的 ESBLs 和/或 AmpC 背景相关。许多厄他培南不敏感菌株具有克隆相关性,并携带各种组合的β-内酰胺酶。

相似文献

4
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.泰国产 NDM-1 和 IMP-14a 型肠杆菌科细菌的出现。
J Antimicrob Chemother. 2012 Nov;67(11):2626-30. doi: 10.1093/jac/dks267. Epub 2012 Jul 13.

引用本文的文献

5
Machine Learning Models Identify Inhibitors of New Delhi Metallo-β-lactamase.机器学习模型鉴定新德里金属β-内酰胺酶抑制剂。
J Chem Inf Model. 2024 May 27;64(10):3977-3991. doi: 10.1021/acs.jcim.3c02015. Epub 2024 May 10.
6
Detection of NDM-1 and OXA-10 Co-Producing Clinical Isolate.NDM-1和OXA-10共产生临床分离株的检测
Infect Drug Resist. 2023 Aug 15;16:5319-5328. doi: 10.2147/IDR.S418131. eCollection 2023.

本文引用的文献

2
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt.埃及鲍曼不动杆菌携带 NDM-2 碳青霉烯酶。
J Antimicrob Chemother. 2011 Jun;66(6):1260-2. doi: 10.1093/jac/dkr135. Epub 2011 Mar 21.
3
Emergence of NDM-1-producing Acinetobacter baumannii in China.中国出现产 NDM-1 鲍曼不动杆菌。
J Antimicrob Chemother. 2011 Jun;66(6):1255-9. doi: 10.1093/jac/dkr082. Epub 2011 Mar 10.
4
The new medical challenge: why NDM-1? Why Indian?新的医学挑战:为何是NDM-1?为何源自印度?
Expert Rev Anti Infect Ther. 2011 Feb;9(2):137-41. doi: 10.1586/eri.10.159.
8
Emerging carbapenemases: a global perspective.新兴碳青霉烯酶:全球视角。
Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S8-14. doi: 10.1016/S0924-8579(10)70004-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验